Cargando…

Blood-Cell-Based Inflammatory Markers as a Useful Tool for Early Diagnosis in Colorectal Cancer

BACKGROUND: Systemic inflammation seems to be involved in the pathogenetic pathways of colorectal cancer (CRC). Analytical markers that reflect the inflammatory status, such as neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR) or systemic immune-inflammation index (SII), have been p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hernandez-Ainsa, Maria, Velamazan, Raul, Lanas, Angel, Carrera-Lasfuentes, Patricia, Piazuelo, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252519/ https://www.ncbi.nlm.nih.gov/pubmed/35795635 http://dx.doi.org/10.3389/fmed.2022.843074

Ejemplares similares

Fecal Hemoglobin Concentration, a Good Predictor of Risk of Advanced Colorectal Neoplasia in Symptomatic and Asymptomatic Patients
por: Navarro, Mercedes, et al.
Publicado: (2019)

Evidence-Based Selection on the Appropriate FIT Cut-Off Point in CRC Screening Programs in the COVID Pandemic
por: Aznar-Gimeno, Rocío, et al.
Publicado: (2021)

Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance
por: Navarro, Mercedes, et al.
Publicado: (2020)

Serum lipid mediator profiles in COVID-19 patients and lung disease severity: a pilot study
por: Irún, Pilar, et al.
Publicado: (2023)

Genetic susceptibility in the development of colorectal adenomas according to family history of colorectal cancer
por: Gargallo, Carla J., et al.
Publicado: (2018)

Familial Colorectal Cancer and Genetic Susceptibility: Colorectal Risk Variants in First-Degree Relatives of Patients With Colorectal Cancer
por: Gargallo-Puyuelo, Carla J., et al.
Publicado: (2021)

The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic in colorectal cancer diagnosis and presentation
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2023)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020)

Management of Helicobacter Pylori Infection and Effectiveness Rates in Daily Clinical Practice in Spain: 2010–2019
por: Ariño Pérez, Inés, et al.
Publicado: (2022)

A Patient Self-Made Point-of-Care Fecal Test Improves Diagnostic Accuracy Compared with Fecal Calprotectin Alone in Inflammatory Bowel Disease Patients
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2021)

Omega-3 Polyunsaturated Fatty Acids and Their Bioactive Metabolites in Gastrointestinal Malignancies Related to Unresolved Inflammation. A Review
por: Irún, Pilar, et al.
Publicado: (2019)

Analysis of blood markers for early colorectal cancer diagnosis
por: Bayo Calero, Juan, et al.
Publicado: (2022)

A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2023)

Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects
por: Irún, Pilar, et al.
Publicado: (2023)

Editorial: Insights in gastroenterology: 2021
por: Lanas, Angel, et al.
Publicado: (2022)

Editorial: Improving the gut microbiome: applications of fecal transplantation in disease
por: García-Mateo, Sandra, et al.
Publicado: (2023)

The impact of COVID-19 pandemic in the diagnosis and management of colorectal cancer patients
por: Domper-Arnal, María José, et al.
Publicado: (2022)

Proton Pump Inhibitors Display Antitumor Effects in Barrett's Adenocarcinoma Cells
por: Chueca, Eduardo, et al.
Publicado: (2016)

Blood Cultures in the Early Diagnosis of Enteric Fever
Publicado: (1909)

Editorial: Current omics-based approaches as tools for improving the understanding, diagnosis and management of inflammatory lung disease
por: Tejera, Paula, et al.
Publicado: (2023)

Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease
por: Sang, Chao, et al.
Publicado: (2021)

Consumo de medicamentos en población adulta: influencia del autoconsumo
por: Carrera-Lasfuentes, Patricia, et al.
Publicado: (2013)

Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype
por: Carrera-Lasfuentes, Patricia, et al.
Publicado: (2017)

Peripheral Inflammatory Blood Markers in Diagnosis of Glioma and IDH Status
por: Sharma, Gaurav, et al.
Publicado: (2021)

Procalcitonin levels in maternal serum and cord blood as marker for diagnosis of early onset neonatal sepsis
por: Yadav, Puja, et al.
Publicado: (2023)

The value of 7 peripheral blood serum ratios in diagnosis and prediction of disease activity of patients within inflammatory bowel disease individuals
por: Pan, Jun, et al.
Publicado: (2023)

Efficient Assay and Marker Significance of NAD(+) in Human Blood
por: Balashova, Natalia V., et al.
Publicado: (2022)

Indications and hemoglobin thresholds for red blood cell transfusion and iron replacement in adults with gastrointestinal bleeding: An algorithm proposed by gastroenterologists and patient blood management experts
por: Montoro, Miguel, et al.
Publicado: (2022)

Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research
por: Angus, Hamish C. K., et al.
Publicado: (2020)

Colorectal cancer population screening programs worldwide in 2016: An update
por: Navarro, Mercedes, et al.
Publicado: (2017)

Correlation between inflammatory marker and lipid metabolism in patients with uterine leiomyomas
por: Duan, Yanan, et al.
Publicado: (2023)

Utilización de servicios sanitarios en ancianos (España 2006-2012): influencia del nivel de salud y de la clase social
por: Aguilar-Palacio, Isabel, et al.
Publicado: (2016)

Impact of the lockdown period due to the COVID-19 pandemic in patients with inflammatory bowel disease
por: Refaie, Engy, et al.
Publicado: (2022)

Impact of the lockdown period due to the COVID-19 pandemic in patients with inflammatory bowel disease
por: Refaie, Engy, et al.
Publicado: (2022)

The Role of circRNAs in the Diagnosis of Colorectal Cancer: A Meta-Analysis
por: Li, Ru-Dong, et al.
Publicado: (2021)

Antitumor effects of lactate transport inhibition on esophageal adenocarcinoma cells
por: Grasa, Laura, et al.
Publicado: (2022)

Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions
por: Copaescu, Ana Maria, et al.
Publicado: (2022)

Monitoring Patient Response to Pembrolizumab With Peripheral Blood Exhaustion Marker Profiles
por: Graves, Moira, et al.
Publicado: (2019)

ASO Author Reflections: Postoperative Inflammatory Markers as a Surveillance Tool in Colorectal Peritoneal Carcinomatosis
por: Tan, Joey Wee-Shan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fbe4tmt1pv485jca76gi2s19u3